Apixaban for Prevention of Acute Ischemic Events – 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome (APPRAISE-2) - Clinicaltrials.gov.
Accessed May 20, 2010.